PMVP icon

PMV Pharmaceuticals
PMVP

Overview Fund Activity

120 hedge funds and large institutions have $614M invested in PMV Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 43 increasing their positions, 32 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
120
Holders Change
+15
Holders Change %
+14.29%
% of All Funds
2.08%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.07%
New
25
Increased
43
Reduced
32
Closed
10
Calls
$558K
Puts
$366K
Net Calls
+$192K
Net Calls Change
-$4.91M

Top Buyers

1
WP
1
Woodline Partners
California
$10.7M
2
BBA
2
Baker Bros. Advisors
New York
$3.83M
3
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$4.34M
4
MPAM
4
Monarch Partners Asset Management
Massachusetts
$2.5M
5
Millennium Management
5
Millennium Management
New York
$1.91M

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$15.6M
2
State Street
2
State Street
Massachusetts
$46.4M
3
Citadel Advisors
3
Citadel Advisors
Florida
$11.5M
4
CC
4
Casdin Capital
New York
$0
5
PHS
5
PFM Health Sciences
California
$10.2M
Name Holding Trade Value Shares
Change 		Shares
Change %
HTC
126
Hershey Trust Company
Pennsylvania
– -$133K -9,346 Closed
CM
127
Caption Management
Oklahoma
– -$61K -4,285 Closed
QT
128
Quantbot Technologies
New York
– -$26K -1,856 Closed
PFS
129
Prospera Financial Services
Texas
– -$2K -136 Closed
2 3 4 5
6